American Journal of Epidemiology Vol. 140, No. 5: 439-452
Copyright © 1994 by The Johns Hopkins University School of Hygiene and Public Health
research-article |
Longitudinal Patterns and Correlates of Hormone Replacement Therapy Use in Middle-aged Women
1New England Research Institute, Inc. Watertown, MA.
2Technical Development Corporation Boston, MA.
Reprint requests to Dr. Sonja M. McKinlay, New England Research Institute, Inc., 9 Galen Street, Watertown, MA 02172
Patterns of hormone replacement therapy (HAT) use over time and predictors of initiating or discontinuing use were examined in a longitudinal study. A cohort of 2,425 women aged 45–55 years Identified from a population-based random survey in Massachusetts in 1981–1982 was followed by six telephone interviews, 9 months apart. Cohort participants were either premenopausal (66.8%) or in early perimeno pause (33.2%). During the study, prevalence of use was low overall (12.3%) and was considerably higher for surgical menopause (45%) than for peri- (9.3%), natural (4.5%), or premenopause (1.5%). Predictors of HAT uptake and discontinuation (from time t - 1 to time t) were examined by repeated-measures logistic regression, stratified by surgical status. For surgical menopause, the only significant predictor of HRT uptake was recent surgery (odds ratio = 4.4; 95% confidence Interval 2.73–7.22), while for nonsurgical subjects, menopausal status (primarily perimenopause), prior use of HRT, health care utilization, hot flashes, alcohol consumption, regular exercise, and leaner body mass were all significant predictors of uptake. Discontinuing HAT was inversely associated with surgical and perimenopause and positively related to prior short-term use and health care utilization. Nonsurgical HAT users had a somewhat more favorable cardiovascular risk profile than did nonusers.
estrogen replacement therapy; follow-up studies; hormones; menopause
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  R. D. Langer Efficacy, Safety, and Tolerability of Low-Dose Hormone Therapy in Managing Menopausal Symptoms J Am Board Fam Med, September 1, 2009; 22(5): 563 - 573. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. A. Hundrup, S. Hoidrup, E. B. Obel, and N. Kr. Rasmussen The validity of self-reported fractures among Danish female nurses: comparison with fractures registered in the Danish National Hospital Register Scand J Public Health, March 1, 2004; 32(2): 136 - 143. [Abstract] [PDF]
|
|
|
|
 |
|
 L J Lambert, J A Y Straton, M W Knuiman, and H C Bartholomew Health status of users of hormone replacement therapy by hysterectomy status in Western Australia J Epidemiol Community Health, April 1, 2003; 57(4): 294 - 300. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. A. Hundrup, H. Thoning, E. B. Obel, N. K. Rasmussen, and J. Philip Lifestyle factors and choice of hormone replacement therapy among Danish nurses Scand J Public Health, January 1, 2002; 30(1): 47 - 53. [Abstract] [PDF]
|
|
|
|
 |
|
 J. C. Prior, S. A. Kirkland, L. Joseph, N. Kreiger, T. M. Murray, D. A. Hanley, J. D. Adachi, Y. M. Vigna, C. Berger, L. Blondeau, et al. Oral contraceptive use and bone mineral density in premenopausal women: cross-sectional, population-based data from the Canadian Multicentre Osteoporosis Study Can. Med. Assoc. J., October 1, 2001; 165(8): 1023 - 1029. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. H. Arjmandi The Role of Phytoestrogens in the Prevention and Treatment of Osteoporosis in Ovarian Hormone Deficiency J. Am. Coll. Nutr., October 1, 2001; 20(90005): 398S - 402. [Abstract] [Full Text]
|
|
|
|
 |
|
 E. B. Gold, J. Bromberger, S. Crawford, S. Samuels, G. A. Greendale, S. D. Harlow, and J. Skurnick Factors Associated with Age at Natural Menopause in a Multiethnic Sample of Midlife Women Am. J. Epidemiol., May 1, 2001; 153(9): 865 - 874. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Wise, D. E. Stewart, P. Liu, and B. L. Abramson Use of hormone replacement therapy among cardiac patients at a Canadian academic centre Can. Med. Assoc. J., July 1, 1999; 161(1): 33 - 36. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Grover Estrogen replacement for women with cardiovascular disease: Why don't physicians and patients follow the guidelines? Can. Med. Assoc. J., July 1, 1999; 161(1): 42 - 43. [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Prior Perimenopause: The Complex Endocrinology of the Menopausal Transition Endocr. Rev., August 1, 1998; 19(4): 397 - 428. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. W. Walsh, L. H. Kuller, R. A. Wild, S. Paul, M. Farmer, J. B. Lawrence, A. S. Shah, and P. W. Anderson Effects of Raloxifene on Serum Lipids and Coagulation Factors in Healthy Postmenopausal Women JAMA, May 13, 1998; 279(18): 1445 - 1451. [Abstract] [Full Text] [PDF]
|
|